EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹394 Cr | ₹286 Cr | ₹97 Cr | ₹12 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹394 Cr |
| Mar2024 | ₹286 Cr |
| Mar2023 | ₹97 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹13 Cr |
How is Contingent Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹394 Cr | 37.98 | |
| Mar2024 | ₹286 Cr | 194.49 | |
| Mar2023 | ₹97 Cr | 703.28 | |
| Mar2022 | ₹12 Cr | -5.66 | |
| Mar2021 | ₹13 Cr | - | |
Compare Contingent Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹33,097.0 Cr | 3.2% | 3.2% | 25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 3.2% |
3.2% |
25.7% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses